New patent expiration for United Therap drug REMODULIN

Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents…

Source


Comments are closed.

Biotechblog